Jungbunzlauer is pleased to announce a significant expansion through the establishment of a new Biogums production facility at its site in Port Colborne, Canada. This strategic move aims to enhance capacity to meet the growing demand for high-quality products, further solidifying the commitment to de...
来自 EBSCO 喜欢 0 阅读量: 20 摘要: Reports the completion of the construction for a cyclic guanosine monophosphate (cGMP) bio-organic synthesis and purification plant of Sigma-Aldrich located at Sigma's complex in Saint Louis. Key features of the plant. 年份: 1999 ...
BioBuilds: A Model for Long Term Sustainability of Open Source BioinformaticsMueller, Christopher
Fully Loaded Retro Gaming Builds & Retro Arcade Nostalgia- Batocera Builds, RetroFE Builds, CoinOps Versions, Raspberry Pi, Retropie, Arcade, Teknoparrot &
GPIO Reader 2 by biotinker Logic analyzer by g3gg0 How to use LORA Terminal by aafksab MagSpoof (WIP) by zacharyweiss Read mode by hummusec - + GPIO & Power fixes Mx2125 Dual-Axis Accelerometer by jamisonderek MH-Z19 - CO2 sensor by meshchaninov ...
Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug UK is becoming an 'outlier' for pharma, hitting investment Sofinnova closes new fund and backs a trio of new biotechs AZ builds in China, as J&J ramps up its US investments Oncology Quantro Therapeutics and the future of drug...
Plus, news about Biocon Biologics, Eris Lifesciences, Aprea Therapeutics and Pi Health: Biotheus expands ADC deal with Hansoh Pharmaceutical: Under the extended pact, Hansoh will get ...
Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up Reseting focus {{ message }} noble-assets / cctp-private-builds Public Notifications You must be signed in to change notification settings Fork 0 Star 0 ...
Banners installed on Harbor DriveSamsung Biologics made a scene at the 2024 BIO International Convention held between June 3-6 in San Diego. The company shared updates on its strengthened CDO capabilities and developments regarding capacity expansion and
Google Cloud and Ginkgo Bioworks have started a five-year partnership to bring artificial intelligence to biotech in areas including genomics, protein studies, and infectious disease preparedness. Ginkgo is committing more than $250 million over the next five years to the alliance – with Google ...